Serum xylosyltransferase activity in diabetic patients as a possible marker of reduced proteoglycan biosynthesis.

about

Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum.

P2860

Q37248241-FBBA9C18-1B18-4D3B-B9FC-ED3139C478EF

P2860

Serum xylosyltransferase activity in diabetic patients as a possible marker of reduced proteoglycan biosynthesis.

Item

http://www.wikidata.org/entity/Q36906253

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Serum xylosyltransferase activ ...... ced proteoglycan biosynthesis.

@en

type

Item

label

Serum xylosyltransferase activ ...... ced proteoglycan biosynthesis.

@en

prefLabel

Serum xylosyltransferase activ ...... ced proteoglycan biosynthesis.

@en

P1476

Serum xylosyltransferase activ ...... ced proteoglycan biosynthesis.

@en

P2093

Christian Götting

http://www.w3.org/2001/XMLSchema#string

Joachim Kuhn

http://www.w3.org/2001/XMLSchema#string

Knut Kleesiek

http://www.w3.org/2001/XMLSchema#string

P2860

Biochemistry and molecular cell biology of diabetic complications

High-glucose-induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cells

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

Cloning and recombinant expression of active full-length xylosyltransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II.

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.

Human xylosyltransferases in health and disease.

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Measurement of fibrosis marker xylosyltransferase I activity by HPLC electrospray ionization tandem mass spectrometry.

Pathogenesis of diabetic vascular disease: evidence for the role of reduced heparan sulfate proteoglycan.

High glucose-induced alterations in subendothelial matrix perlecan leads to increased monocyte binding.

P304

2018-2019

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC08-0909

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51423962

http://www.w3.org/2001/XMLSchema#string

P698

18650370

http://www.w3.org/2001/XMLSchema#string

P932

2551647

http://www.w3.org/2001/XMLSchema#string

Serum xylosyltransferase activity in diabetic patients as a possible marker of reduced proteoglycan biosynthesis.

about

P2860

P2860

Serum xylosyltransferase activity in diabetic patients as a possible marker of reduced proteoglycan biosynthesis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932